In humans, variants in the CD36 gene have been associated with lipid and glucose metabolism abnormality and altered susceptibility to metabolic syndrome and diabetes-associated coronary disease (Love-Gregory et al., 2016). The gene discussed is CD36; the disease is diabetes mellitus.